Enzyme inhibition kinetics and molecular interactions of patatin peptides with angiotensin I-converting enzyme and renin

International Journal of Biological Macromolecules

Volumn 101, Issue , 2017, Pages 207-213

  Fu, Yu ^a   Alashi, Adeola M ^b   Young, Jette F ^a   Therkildsen, Margrethe ^a   Aluko, Rotimi E ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ACE; Kinetics; Molecular docking; Patatin peptides; Renin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PATATIN; PEPTIDE; PROPYLARGINYLTYROSINE; RENIN; TRYPTOPHYLGLYCINE; UNCLASSIFIED DRUG; CARBOXYLESTERASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PATATIN PROTEIN, SOLANUM TUBEROSUM; PEPTIDE FRAGMENT; PLANT PROTEIN;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; HYDROGEN BOND; MOLECULAR DOCKING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; KINETICS; METABOLISM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBOXYLIC ESTER HYDROLASES; CATALYTIC DOMAIN; HUMANS; KINETICS; MOLECULAR DOCKING SIMULATION; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PLANT PROTEINS; RENIN;

EID: 85016062607     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2017.03.054     Document Type: Article

References (33)

1. [1] Papadogiannis, D.E., Protogerou, A.D., Blood pressure variability: a confounder and a cardiovascular risk factor. Hypertens. Res. 34:2 (2011), 162–163.
2. [2] Crowley, S.D., Coffman, T.M., Recent advances involving the renin-angiotensin system. Exp. Cell Res. 318:9 (2012), 1049–1056.
3. [3] Daien, V., Duny, Y., Ribstein, J., d. Cailar, G., Mimran, A., Villain, M., Daures, J.P., Fesler, P., Treatment of hypertension with Renin–Angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. Am. J. Hypertens. 25:1 (2012), 126–132.
4. [4] Connelly, K., Advani, A., Advani, S., Zhang, Y., Thai, K., Thomas, S., Krum, H., Kelly, D., Gilbert, R., Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction. Cardiovasc. Ther. 31:2 (2013), 84–91.
5. [5] He, R., Aluko, R.E., Ju, X.-R., Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme. PLoS One, 9(3), 2014.
6. [6] Khalesi, M., Jahanbani, R., Riveros-Galan, D., Sheikh-Hassani, V., Sheikh-Zeinoddin, M., Sahihi, M., Winterburn, J., Derdelinckx, G., Moosavi-Movahedi, A.A., Antioxidant activity and ACE-inhibitory of Class II hydrophobin from wild strain Trichoderma reesei. Int. J. Biol. Macromol. 91 (2016), 174–179.
7. [7] Aluko, R.E., Antihypertensive peptides from food proteins. Ann. Rev. Food Sci. Technol. 6 (2015), 235–262.
8. [8] Fu, Y., Wu, W., Zhu, M., Xiao, Z., In silico assessment of the potential of patatin as a precursor of bioactive peptides. J. Food Biochem. 40:3 (2016), 366–370.
9. [9] Udenigwe, C.C., Lin, Y.S., Hou, W.C., Aluko, R.E., Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. J. Funct. Foods 1:2 (2009), 199–207.
10. [10] Girgih, A.T., He, R., Aluko, R.E., Kinetics and molecular docking studies of the inhibitions of angiotensin converting enzyme and renin activities by hemp seed (Cannabis sativa L.) peptides. J. Agric. Food Chem. 62:18 (2014), 4135–4144.
11. [11] Li, H., Aluko, R.E., Structural modulation of calmodulin and calmodulin-dependent protein kinase II by pea protein hydrolysates. Int. J. Food Sci. Nutr. 57:3–4 (2006), 178–189.
12. [12] Huang, G.J., Lu, T.L., Chiu, C.S., Chen, H.J., Wu, C.H., Lin, Y.C., Hsieh, W.T., Liao, J.C., Sheu, M.J., Lin, Y.H., Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro. Bot. Stud. 52:3 (2011), 257–264.
13. [13] Huang, G.J., Chen, H.J., Susumu, K., Wu, J.B., Hou, W.C., Wu, C.H., Sheu, M.J., Huang, S.S., Lin, Y.H., Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro. Bot. Stud. 52:1 (2011), 15–22.
14. [14] He, R., Malomo, S.A., Alashi, A., Girgih, A.T., Ju, X., Alulzo, R.E., Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. J. Funct. Foods 5:2 (2013), 781–789.
15. [15] Aluko, R.E., Structure and function of plant protein-derived antihypertensive peptides. Curr. Opin. Food Sci. 4 (2015), 44–50.
16. [16] Wu, J.P., Aluko, R.E., Nakai, S., Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem. 54:3 (2006), 732–738.
17. [17] Li, H., Aluko, R.E., Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J. Agric. Food Chem. 58:21 (2010), 11471–11476.
18. [18] Fitzgerald, C., Mora-Soler, L., Gallagher, E., O'Connor, P., Prieto, J., Soler-Vila, A., Hayes, M., Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga palmaria palmata. J. Agric. Food Chem. 60:30 (2012), 7421–7427.
19. [19] Udenigwe, C.C., Li, H., Aluko, R.E., Quantitative structure-activity relationship modeling of renin-inhibiting dipeptides. Amino Acids 42:4 (2012), 1379–1386.
20. [20] Cornish-Bowden, A., Principles of Enzyme Kinetics. 2014, Elsevier.
21. [21] Girgih, A.T., Udenigwe, C.C., Li, H., Adebiyi, A.P., Aluko, R.E., Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. J. Am. Oil Chem. Soc. 88:11 (2011), 1767–1774.
22. [22] Hridya, H., Amrita, A., Sankari, M., Doss, C.G.P., Gopalakrishnan, M., Gopalakrishnan, C., Siva, R., Inhibitory effect of brazilein on tyrosinase and melanin synthesis: kinetics and in silico approach. Int. J. Biol. Macromol. 81 (2015), 228–234.
23. [23] Pina, A.S., Roque, A.C.A., Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. J. Mol. Recognit. 22:2 (2009), 162–168.
24. [24] Schmid, F., Spectral methods of characterizing protein conformation and conformational changes. Protein Struct., 1989, 251–285.
25. [25] Yuan, L., WU, J., Aluko, R.E., Ye, X., Kinetics of renin inhibition by sodium houttuyfonate analogs. Biosci. Biotechnol. Biochem. 70:9 (2006), 2275–2280.
26. [26] Kobayashi, Y., Yamauchi, T., Katsuda, T., Yamaji, H., Katoh, S., Angiotensin-I converting enzyme (ACE) inhibitory mechanism of tripeptides containing aromatic residues. J. Biosci. Bioeng. 106:3 (2008), 310–312.
27. [27] Tanzadehpanah, H., Asoodeh, A., Saberi, M.R., Chamani, J., Identification of a novel angiotensin-I converting enzyme inhibitory peptide from ostrich egg white and studying its interactions with the enzyme. Innov. Food Sci. Emerg. Technol. 18 (2013), 212–219.
28. [28] Natesh, R., Schwager, S.L.U., Evans, H.R., Sturrock, E.D., Acharya, K.R., Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 43:27 (2004), 8718–8724.
29. [29] Chaudhary, S., Vats, I.D., Chopra, M., Biswas, P., Pasha, S., Effect of varying chain length between P-1 and P-1’ position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors. Bioorg. Med. Chem. Lett. 19:15 (2009), 4364–4366.
30. [30] Fu, Y., Young, J.F., Rasmussen, M.K., Dalsgaard, T.K., Lametsch, R., Aluko, R.E., Therkildsen, M., Angiotensin I?converting enzyme?inhibitory peptides from bovine collagen: insights into inhibitory mechanism and transepithelial transport. Food Res. Int. 89:Part 1 (2016), 373–381.
31. [31] Wu, Q., Du, J., Jia, J., Kuang, C., Production of ACE inhibitory peptides from sweet sorghum grain protein using alcalase: hydrolysis kinetic, purification and molecular docking study. Food Chem. 199 (2016), 140–149.
32. [32] Xie, C.-l., Choung, S.-y., Cao, G.-p., Lee, K.W., Choi, Y.J., In silico investigation of action mechanism of four novel angiotensin-I converting enzyme inhibitory peptides modified with Trp. J. Funct. Foods 17 (2015), 632–639.
33. [33] Sielecki, A.R., Hayakawa, K., Fujinaga, M., Murphy, M.E., Fraser, M., Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 angstroms resolution. Science, 243(4896), 1989, 1346.